Amalgamated Bank Cue Biopharma, Inc. Transaction History

Amalgamated Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$1.77 - $3.09 $6,596 - $11,516	-3,727 Reduced 76.19%	1,165 $2,000
Q4 2023 Feb 06, 2024	SELL	$1.72 - $3.1 $596 - $1,075	-347 Reduced 6.62%	4,892 $13,000
Q2 2023 Aug 11, 2023	BUY	$3.11 - $4.91 $16,293 - $25,723	5,239 New	5,239 $19,000
Q2 2022 Aug 15, 2022	SELL	$2.49 - $5.92 $12,512 - $29,748	-5,025 Closed	0 $0
Q1 2022 Jun 30, 2022	BUY	$4.41 - $12.28 $22,160 - $61,707	5,025 New	5,025 $25,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.